Data / Form D filings / Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc.: Form D filings
Cirius Therapeutics, Inc., a biotechnology company in Grand Rapids, MI, filed 6 Form D notices with the SEC between 2017 and 2025. The latest, on October 8, 2025, reports $800,000 sold of a $1.2 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3133 ORCHARD VISTA DR. SW, Grand Rapids, MI, 49546
- Phone
- (616) 450-5552
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1702956
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8, 2025 | New notice | $1,200,000 | $800,000 | $400,000 | 22 | Oct 7, 2025 | sec.gov |
| Oct 15, 2024 | New notice | $1,600,000 | $1,000,000 | $600,000 | 22 | Oct 8, 2024 | sec.gov |
| Aug 20, 2024 | New notice | $1,300,000 | $1,300,000 | 24 | Jul 12, 2024 | sec.gov | |
| May 14, 2019 | New notice | $7,499,972 | $7,499,972 | 29 | May 6, 2019 | sec.gov | |
| Aug 30, 2018 | New notice | $9,000,000 | $9,000,000 | 30 | Aug 23, 2018 | sec.gov | |
| Apr 10, 2017 | New notice | $40,500,000 | $30,000,003 | $10,499,997 | 21 | Mar 24, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael A Jandernoa | Director | |
| Robert A Beardsley | Executive Officer | |
| Robert A Zerbe | Director | |
| David A Van Andel | Director | |
| Jerry A Callahan | Executive Officer |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Oct 6, 2025 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cirius Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.